Position in AKBA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,644,129
+$329,378 QoQ
Shares Held
3,196,605
+34.0% QoQ
Ownership
1.15%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 170 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Derivatives in AKBA
reported options exposure · as of Mar 31, 2022CallValue
$502,600
CallShares
700,000
PutValue
$73,092
PutShares
101,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $1,140,219,030 across 49 Drug Manufacturers - Specialty & Generic names. AKBA ranks #26 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
409,074 | $221,648,565 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
3,853,212 | $179,212,890 | |
| 3 | ZTS |
Zoetis Inc.
|
1,813,759 | $130,336,721 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,265,321 | $110,629,075 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
2,098,945 | $86,119,713 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
2,725,889 | $67,084,128 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
507,207 | $41,986,595 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
336,399 | $37,320,105 |
All Filings in AKBA
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,644,129 | 3,196,605 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,314,751 | 2,384,713 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,662,085 | 1,653,469 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,800,257 | 2,857,237 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,875,136 | 2,163,499 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,311,395 | 1,203,852 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $322,329 | 169,647 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $26,723 | 20,245 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $46,598 | 45,685 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,976,780 | 3,266,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,223,983 | 2,599,987 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,480,106 | 3,052,725 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,835,451 | 2,005,958 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $510,136 | 910,958 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $774,577 | 1,342,422 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,099,951 | 3,480,858 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,890,023 | 5,354,175 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $73,092 | 101,800 | Put | Sole | 2022-05-16 | |
| 2022-03-31 | $502,600 | 700,000 | Call | Sole | 2022-05-16 | |
| 2022-03-31 | $1,889,642 | 2,631,814 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,347,864 | 1,923,834 | Shares | Sole | 2022-02-14 | |
| 2021-06-30 | $1,004,175 | 264,954 | Shares | Sole | 2021-08-16 | |
| 2021-06-30 | $379,000 | 100,000 | Put | Sole | 2021-08-16 | |
| 2021-03-31 | $507,750 | 150,000 | Put | Sole | 2021-05-17 | |
| 2021-03-31 | $4,563,971 | 1,348,293 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,680,000 | 600,000 | Call | Sole | 2021-02-16 | |
| 2020-12-31 | $5,450,219 | 1,946,507 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $5,540,267 | 2,207,278 | Shares | Sole | 2020-11-16 | |
| 2020-03-31 | $6,520,429 | 860,215 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||